Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy (Gemtrans)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
University of Oxford
Information provided by (Responsible Party):
Suzanne Rowland, Christie Hospital NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT01343121
First received: April 7, 2011
Last updated: January 26, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2018
  Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)